Contact Us: 1-800-981-9883
On April 4, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated the Biosafety Laboratory Guidance for Handling and Processing Mpox Specimens webpage to include information about clade I and to clarify select agent requirements. CDC also updated the How to Report Results from Orthopoxvirus, Non-Variola Orthopoxvirus, and Mpox Virus Diagnostic Testing webpage…
On April 5, 2024, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) message about a recently confirmed human infection with highly pathogenic avian influenza (HPAI) A(H5N1) virus in the United States following exposure to presumably infected dairy cattle.
Our quest for longevity has long captivated the attention of both the scientific community and the general public, particularly the complex mechanisms of aging at the molecular level. Just as different parts of a car or aspects of a house show signs of wear at varying rates, so too do the organs within our body…
On March 26, 2024, the Clinical Laboratory Improvement Advisory Committee (CLIAC) published information about the upcoming virtual CLIAC meeting, which will take place April 10. The biannual CLIAC meetings are an excellent opportunity for laboratory professionals to receive quality and safety updates from CDC, the Centers for Medicare & Medicaid Services (CMS), and the Food…
On March 21, 2024, the U.S. Food and Drug Administration (FDA) published a notice in the Federal Register about the revocation of six Emergency Use Authorizations (EUAs) of in vitro diagnostic devices for detection and/or diagnosis of COVID-19.
Laboratory Outreach Communication System (LOCS) reports that the U.S. Department of Transportation (DOT) has released a Safety Advisory Notice regarding the classification of monkeypox virus (MPXV) specimens and waste. This Safety Advisory Notice addresses the transportation and disposal of material suspected or confirmed to contain MPXV. While the risk for Clade I mpox cases in the U.S.…
The Centers for Medicare and Medicaid Services (CMS) has granted COLA, a leading private, non-profit laboratory accreditation organization, an extension of its deeming authority for an additional six years under the Clinical Laboratory Improvement Amendments of 1988 (CLIA 88). This reapproval solidifies COLA’s standing as a trusted accreditor of clinical laboratories nationwide. Renewal of deeming…
Patient Safety Awareness Week, celebrated every March, casts a spotlight on a critical aspect of healthcare: patient safety. It is a time when the healthcare community, including pathologists and laboratory professionals, renews its commitment to fostering an environment where errors are not just reported but deeply analyzed without fear of blame. Transparency in testing processes…
Welcome back to the third entry of our series on primary HPV testing in cervical cancer screening. In this installment, we take a retrospective look at how HPV testing has revolutionized cervical cancer detection since its introduction in the early 2000s. Applications of HPV Testing in Cervical Cancer Screening Over the past two decades, HPV…
